Gianise Toboliski Bongiorni1, Marjeane Cristina Jaques Hockmuller1, Cristini Klein2, Ápio Cláudio Martins Antunes3. 1. Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Ciências Médicas - Ciência Cirúrgica, Porto Alegre RS, Brasil. 2. Universidade Federal do Rio Grande do Sul, Programa de Pós-Graduação em Ciências Médicas, Porto Alegre RS, Brasil. 3. Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Serviço de Neurocirurgia, Porto Alegre RS, Brasil.
Abstract
OBJECTIVE: To assess, by Rankin scale, the functional disability of patients who had a malignant middle cerebral artery (MCA) ischemic stroke, who underwent decompressive craniotomy (DC) within the first 30 days. METHODS: A cross-sectional study in a University hospital. Between June 2007 and December 2014, we retrospectively analyzed the records of all patients submitted to DC due to a malignant MCA infarction. The mortality rate was defined during the hospitalization period. The modified outcome Rankin score (mRS) was measured 30 days after the procedure, for stratification of the quality of life. RESULTS: The DC mortality rate was 30% (95% CI 14.5 to 51.9) for the 20 patients reported. The mRS 30 days postoperatively was ≥ 4 [3.3 to 6] for all patients thereafter. CONCLUSION: DC is to be considered a real alternative for the treatment of patients with a malignant ischemic MCA infarction.
OBJECTIVE: To assess, by Rankin scale, the functional disability of patients who had a malignant middle cerebral artery (MCA) ischemic stroke, who underwent decompressive craniotomy (DC) within the first 30 days. METHODS: A cross-sectional study in a University hospital. Between June 2007 and December 2014, we retrospectively analyzed the records of all patients submitted to DC due to a malignant MCA infarction. The mortality rate was defined during the hospitalization period. The modified outcome Rankin score (mRS) was measured 30 days after the procedure, for stratification of the quality of life. RESULTS: The DC mortality rate was 30% (95% CI 14.5 to 51.9) for the 20 patients reported. The mRS 30 days postoperatively was ≥ 4 [3.3 to 6] for all patients thereafter. CONCLUSION: DC is to be considered a real alternative for the treatment of patients with a malignant ischemic MCA infarction.
Authors: Maria Luz Alonso-Alonso; Ana Sampedro-Viana; Manuel Rodríguez-Yáñez; Iria López-Dequidt; José M Pumar; Antonio J Mosqueira; Alberto Ouro; Paulo Ávila-Gómez; Tomás Sobrino; Francisco Campos; José Castillo; Pablo Hervella; Ramón Iglesias-Rey Journal: J Clin Med Date: 2022-05-19 Impact factor: 4.964
Authors: Ana Paula Gaspari; Elaine Drehmer de Almeida Cruz; Josemar Batista; Francine Taporosky Alpendre; Viviane Zétola; Marcos Christiano Lange Journal: Rev Lat Am Enfermagem Date: 2019-10-14